14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:PTX
Delisted

Pernix Therapeutics Holdings Stock Signals

$0.0289
+0 (+0%)
At Close: Sep 17, 2019

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 28 days ( 0 % )
Last Price $0.0289 0 %
High/ Low $0.0289 - $0.0289 0%
Chg 7 Days N/A $0.0289 $0.0289
Chg 30 Days N/A $0.0289 $0.0289
Chg 12 mos -96.81 % $0.91 $0.0289
Trend - 3 mos 9.10 % Width: 32.11 %
Trend - 12 mos -42.87 % Width: 313.08 %
Pred. range - 3 mos $0.0260 - $0.0343 -10.16 % - 18.68 %
Pred. range - 12 mos N/A - $0.718 -100.00 % - 2,385.64 %
Short MA avg 3 mos Sell Jul 02, 2019 - 54 days
Long MA avg 3 mos Sell Aug 12, 2019 - 26 days
Short/Long MA avg 3 mos Sell Aug 12, 2019 - 26 days
Short MA avg 12 mos Buy Jun 24, 2019 - 60 days
Long MA avg 12 mos Buy Aug 23, 2019 - 17 days
Short/Long MA avg 12 mos Buy Aug 23, 2019 - 17 days
Pivot Short Sell Sep 16, 2019 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Pernix Therapeutics Holdings

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products. The company’s products comprise Treximet, a medication indicated for the acute treatment of migraine attacks in adults; Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a medication indicated for the treatment of insomnia characterized by difficulty with sleep mainten... PTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT